Short answer
Gossamer Bio, Inc. (GOSS) filed an 8-K current report with the SEC on July 1, 2026 reporting Item 7.01 (Regulation FD Disclosure). Initial conversion rate: 5,347.5936 shares per $1,000 principal amount of 2030 Convertible Notes.
Gossamer Bio, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Initial conversion rate: 5,347.5936 shares per $1,000 principal amount of 2030 Convertible Notes
- Implied conversion price approximately $0.19 per common share, creating substantial potential dilution
- 2030 Convertible Notes carry 7.50% interest and mature in 2030
- Purchase Warrants initial exercise price: $0.34 per whole common share
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Gossamer Bio, Inc. 8-K filings
Get the next GOSS 8-K as it lands
Follow GOSS for push alerts, or ask the research agent what this filing means.